PATH board of directors welcomes Sylvana Q. Sinha

Seattle, October 10, 2022 - PATH’s board of directors is thrilled to welcome Sylvana Q. Sinha as its newest member. Sinha brings extensive global strategic and operational expertise in international law, business, development, and government relations. For more than 20 years, she has collaborated with diverse players across sectors and industries in the Middle East, Africa, and South Asia to deliver impactful governance and legal reforms as well as advocating for women’s rights, gender equality, and social protection.

"We are privileged to have Sylvana join the board as she brings deep expertise in digital health and a unique blend of experience in international law, business, and development. Sylvana is well-equipped to help guide PATH forward into achieving the goals defined in PATH's strategy 2025,” said the Chair of the board of directors, Beth Galetti.

Sinha is currently the CEO of Praava Health in Bangladesh, a leading healthcare company focused on improving health outcomes and patient journeys in emerging markets by integrating digital health tools designed to be efficient, accessible, and scalable with high-quality in-clinic experiences. Praava is currently Bangladesh’s fastest-growing consumer healthcare company, having served more than 400,000 patients to date.

In addition to being a PATH board member, she is also a member of the Council on Foreign Relations, a member of the World Economic Forum’s UHC2030 Private Sector Constituency, and has served on the Task Force on Global Advantage at the Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai.

Sinha graduated from Columbia Law School. She also holds a master's degree in Public Administration / International Development from Harvard's Kennedy School and a Bachelor of Arts (with honors) in Economics and Philosophy from Wellesley College.